Authors:
Jelic, S
Babovic, N
Stamatovic, L
Kreacic, M
Matkovic, S
Popov, I
Citation: S. Jelic et al., Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures - A single-center study, MED ONCOL, 18(3), 2001, pp. 189-195
Authors:
Popov, I
Jelic, S
Radosavljevic, D
Nikolic-Tomasevic, Z
Citation: I. Popov et al., Amsacrine and cisplatin in poor prognosis patients with metastatic transitional cell carcinoma of the urothelium: A phase-II study, EUR UROL, 40(3), 2001, pp. 324-329
Authors:
Nikolic-Tomasevic, Z
Jelic, S
Popov, I
Radosavljevic, D
Mitrovic, L
Citation: Z. Nikolic-tomasevic et al., Tumor 'flare' hypercalcemia - An additional indication for bisphosphonates?, ONCOL-BASEL, 60(2), 2001, pp. 123-126
Authors:
Nikolic-Tomasevic, Z
Jelic, S
Popov, I
Radosavljevic, D
Citation: Z. Nikolic-tomasevic et al., Irinotecan as second-line treatment in metastatic colorectal cancer: Dilemmas regarding patient selection and toxicity prediction, J CHEMOTHER, 12(3), 2000, pp. 244-251
Authors:
Popov, I
Jelic, S
Radulovic, S
Radosavljevic, D
Nikolic-Tomasevic, Z
Citation: I. Popov et al., Eight-hour infusion versus bolus injection of doxorubicin in the EAP regimen in patients with advanced gastric cancer: A prospective randomised trial, ANN ONCOL, 11(3), 2000, pp. 343-348
Citation: I. Popov et G. Lewin, Photochemiluminescent detection of antiradical activity. VI. Antioxidant characteristics of human blood plasma, low density lipoprotein, serum albumin and amino acids during in vitro oxidation, LUMINESCENC, 14(3), 1999, pp. 169-174
Authors:
Popov, I
Jelic, S
Radosavljevic, D
Nikolic-Tomasevic, Z
Citation: I. Popov et al., The role of stable disease in objective response assessment and its impacton survival in advance colorectal cancer: Is "stable disease" a homogenousresponse category?, NEOPLASMA, 46(2), 1999, pp. 132-139